Annual EBITDA
$9.67 M
-$298.03 M-96.86%
31 December 2023
Summary:
Dynavax Technologies annual earnings before interest, taxes, depreciation & amortization is currently $9.67 million, with the most recent change of -$298.03 million (-96.86%) on 31 December 2023. During the last 3 years, it has risen by +$56.51 million (+120.63%). DVAX annual EBITDA is now -96.86% below its all-time high of $307.70 million, reached on 31 December 2022.DVAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$23.28 M
+$4.99 M+27.26%
30 September 2024
Summary:
Dynavax Technologies quarterly earnings before interest, taxes, depreciation & amortization is currently $23.28 million, with the most recent change of +$4.99 million (+27.26%) on 30 September 2024. Over the past year, it has increased by +$5.86 million (+33.61%). DVAX quarterly EBITDA is now -82.47% below its all-time high of $132.79 million, reached on 30 June 2022.DVAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$38.92 M
+$5.86 M+17.71%
30 September 2024
Summary:
Dynavax Technologies TTM earnings before interest, taxes, depreciation & amortization is currently $38.92 million, with the most recent change of +$5.86 million (+17.71%) on 30 September 2024. Over the past year, it has dropped by -$37.18 million (-48.86%). DVAX TTM EBITDA is now -88.56% below its all-time high of $340.08 million, reached on 30 September 2022.DVAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DVAX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.9% | +33.6% | -48.9% |
| 3 y3 years | +120.6% | +198.4% | +326.6% |
| 5 y5 years | +107.2% | +210.8% | +132.4% |
DVAX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -96.9% | +120.6% | -82.5% | +198.4% | -88.6% | +326.6% |
| 5 y | 5 years | -96.9% | +107.2% | -82.5% | +151.8% | -88.6% | +132.4% |
| alltime | all time | -96.9% | +107.2% | -82.5% | +151.8% | -88.6% | +128.8% |
Dynavax Technologies EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.28 M(+27.3%) | $38.92 M(+17.7%) |
| June 2024 | - | $18.29 M(-324.7%) | $33.06 M(+49.1%) |
| Mar 2024 | - | -$8.14 M(-248.4%) | $22.18 M(+129.4%) |
| Dec 2023 | $9.67 M(-96.9%) | $5.48 M(-68.5%) | $9.67 M(-87.3%) |
| Sept 2023 | - | $17.43 M(+135.2%) | $76.10 M(-39.4%) |
| June 2023 | - | $7.41 M(-135.9%) | $125.67 M(-49.9%) |
| Mar 2023 | - | -$20.65 M(-128.7%) | $251.05 M(-18.5%) |
| Dec 2022 | $307.70 M(+221.3%) | $71.92 M(+7.4%) | $307.97 M(-9.4%) |
| Sept 2022 | - | $66.99 M(-49.5%) | $340.08 M(+36.3%) |
| June 2022 | - | $132.79 M(+266.1%) | $249.42 M(+100.1%) |
| Mar 2022 | - | $36.27 M(-65.1%) | $124.66 M(+30.2%) |
| Dec 2021 | $95.75 M(-304.4%) | $104.03 M(-539.6%) | $95.75 M(-657.5%) |
| Sept 2021 | - | -$23.66 M(-394.9%) | -$17.18 M(-198.5%) |
| June 2021 | - | $8.03 M(+9.0%) | $17.43 M(-149.0%) |
| Mar 2021 | - | $7.36 M(-182.7%) | -$35.56 M(-24.1%) |
| Dec 2020 | -$46.84 M(-58.9%) | -$8.90 M(-181.3%) | -$46.84 M(-28.8%) |
| Sept 2020 | - | $10.94 M(-124.3%) | -$65.78 M(-32.7%) |
| June 2020 | - | -$44.97 M(+1047.8%) | -$97.74 M(+13.2%) |
| Mar 2020 | - | -$3.92 M(-85.9%) | -$86.35 M(-24.3%) |
| Dec 2019 | -$114.09 M(-15.5%) | -$27.83 M(+32.4%) | -$114.09 M(-5.0%) |
| Sept 2019 | - | -$21.02 M(-37.4%) | -$120.04 M(-9.2%) |
| June 2019 | - | -$33.58 M(+6.1%) | -$132.14 M(-0.0%) |
| Mar 2019 | - | -$31.66 M(-6.3%) | -$132.18 M(-2.1%) |
| Dec 2018 | -$135.08 M(+48.9%) | -$33.78 M(+2.0%) | -$135.08 M(+4.6%) |
| Sept 2018 | - | -$33.12 M(-1.5%) | -$129.09 M(+9.8%) |
| June 2018 | - | -$33.62 M(-2.7%) | -$117.58 M(+13.7%) |
| Mar 2018 | - | -$34.56 M(+24.3%) | -$103.39 M(+14.0%) |
| Dec 2017 | -$90.72 M(-17.7%) | -$27.79 M(+28.6%) | -$90.71 M(+8.9%) |
| Sept 2017 | - | -$21.61 M(+11.2%) | -$83.30 M(-13.1%) |
| June 2017 | - | -$19.43 M(-11.2%) | -$95.90 M(-8.8%) |
| Mar 2017 | - | -$21.88 M(+7.4%) | -$105.17 M(-4.5%) |
| Dec 2016 | -$110.19 M(+5.1%) | -$20.38 M(-40.4%) | -$110.19 M(-5.2%) |
| Sept 2016 | - | -$34.21 M(+19.2%) | -$116.27 M(+4.0%) |
| June 2016 | - | -$28.71 M(+6.8%) | -$111.80 M(+5.4%) |
| Mar 2016 | - | -$26.89 M(+1.7%) | -$106.11 M(+1.2%) |
| Dec 2015 | -$104.86 M(+17.4%) | -$26.45 M(-11.0%) | -$104.86 M(+5.1%) |
| Sept 2015 | - | -$29.74 M(+29.1%) | -$99.80 M(-0.0%) |
| June 2015 | - | -$23.03 M(-10.2%) | -$99.81 M(-1.5%) |
| Mar 2015 | - | -$25.64 M(+19.8%) | -$101.29 M(+13.4%) |
| Dec 2014 | -$89.28 M(+37.0%) | -$21.40 M(-28.0%) | -$89.28 M(+11.0%) |
| Sept 2014 | - | -$29.74 M(+21.3%) | -$80.45 M(+21.9%) |
| June 2014 | - | -$24.51 M(+79.9%) | -$66.02 M(+13.2%) |
| Mar 2014 | - | -$13.63 M(+8.5%) | -$58.31 M(-10.5%) |
| Dec 2013 | -$65.16 M | -$12.57 M(-17.9%) | -$65.16 M(-9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | -$15.31 M(-8.9%) | -$72.24 M(-2.1%) |
| June 2013 | - | -$16.81 M(-17.9%) | -$73.83 M(+3.6%) |
| Mar 2013 | - | -$20.47 M(+4.2%) | -$71.24 M(+7.3%) |
| Dec 2012 | -$66.39 M(+47.4%) | -$19.65 M(+16.3%) | -$66.39 M(+32.1%) |
| Sept 2012 | - | -$16.90 M(+18.8%) | -$50.25 M(+5.0%) |
| June 2012 | - | -$14.22 M(-9.0%) | -$47.87 M(+10.3%) |
| Mar 2012 | - | -$15.63 M(+346.1%) | -$43.39 M(-3.8%) |
| Dec 2011 | -$45.04 M(-15.4%) | -$3.50 M(-75.9%) | -$45.09 M(-30.3%) |
| Sept 2011 | - | -$14.52 M(+48.9%) | -$64.72 M(+14.8%) |
| June 2011 | - | -$9.75 M(-43.7%) | -$56.37 M(-9.5%) |
| Mar 2011 | - | -$17.32 M(-25.1%) | -$62.27 M(+16.9%) |
| Dec 2010 | -$53.26 M(+333.8%) | -$23.13 M(+275.4%) | -$53.26 M(+29.7%) |
| Sept 2010 | - | -$6.16 M(-60.6%) | -$41.07 M(-8.5%) |
| June 2010 | - | -$15.65 M(+88.5%) | -$44.90 M(+75.1%) |
| Mar 2010 | - | -$8.31 M(-24.1%) | -$25.64 M(+108.9%) |
| Dec 2009 | -$12.28 M(-42.3%) | -$10.95 M(+9.6%) | -$12.28 M(-1048.1%) |
| Sept 2009 | - | -$9.99 M(-377.4%) | $1.29 M(-79.2%) |
| June 2009 | - | $3.60 M(-28.8%) | $6.23 M(-289.1%) |
| Mar 2009 | - | $5.06 M(+92.6%) | -$3.29 M(-84.5%) |
| Dec 2008 | -$21.29 M(-69.0%) | $2.63 M(-151.9%) | -$21.29 M(-42.9%) |
| Sept 2008 | - | -$5.06 M(-14.5%) | -$37.29 M(-26.6%) |
| June 2008 | - | -$5.92 M(-54.3%) | -$50.78 M(-22.3%) |
| Mar 2008 | - | -$12.94 M(-3.3%) | -$65.37 M(-4.2%) |
| Dec 2007 | -$68.61 M(+15.7%) | -$13.38 M(-27.9%) | -$68.26 M(-10.9%) |
| Sept 2007 | - | -$18.54 M(-9.6%) | -$76.62 M(+6.2%) |
| June 2007 | - | -$20.51 M(+29.6%) | -$72.15 M(+10.6%) |
| Mar 2007 | - | -$15.83 M(-27.2%) | -$65.25 M(+13.5%) |
| Dec 2006 | -$59.27 M(+206.2%) | -$21.74 M(+54.5%) | -$57.48 M(+31.8%) |
| Sept 2006 | - | -$14.07 M(+3.3%) | -$43.61 M(+14.0%) |
| June 2006 | - | -$13.61 M(+69.0%) | -$38.26 M(+16.7%) |
| Mar 2006 | - | -$8.06 M(+2.3%) | -$32.80 M(+70.7%) |
| Dec 2005 | -$19.36 M(+42.5%) | -$7.88 M(-9.6%) | -$19.22 M(+21.5%) |
| Sept 2005 | - | -$8.71 M(+6.9%) | -$15.81 M(+48.6%) |
| June 2005 | - | -$8.15 M(-247.6%) | -$10.64 M(+153.5%) |
| Mar 2005 | - | $5.52 M(-223.5%) | -$4.20 M(-69.1%) |
| Dec 2004 | -$13.59 M(-21.0%) | -$4.47 M(+26.4%) | -$13.59 M(-49.7%) |
| Sept 2004 | - | -$3.54 M(+107.3%) | -$27.00 M(+15.2%) |
| June 2004 | - | -$1.71 M(-55.8%) | -$23.43 M(+8.3%) |
| Mar 2004 | - | -$3.87 M(-78.4%) | -$21.63 M(+21.8%) |
| Dec 2003 | -$17.19 M(-4.4%) | -$17.88 M(<-9900.0%) | -$17.76 M(<-9900.0%) |
| Sept 2003 | - | $23.00 K(-76.0%) | $119.00 K(+24.0%) |
| June 2003 | - | $96.00 K | $96.00 K |
| Dec 2002 | -$17.98 M(-7.9%) | - | - |
| Dec 2001 | -$19.53 M(+66.7%) | - | - |
| Dec 2000 | -$11.72 M | - | - |
FAQ
- What is Dynavax Technologies annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Dynavax Technologies?
- What is Dynavax Technologies annual EBITDA year-on-year change?
- What is Dynavax Technologies quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Dynavax Technologies?
- What is Dynavax Technologies quarterly EBITDA year-on-year change?
- What is Dynavax Technologies TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Dynavax Technologies?
- What is Dynavax Technologies TTM EBITDA year-on-year change?
What is Dynavax Technologies annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DVAX is $9.67 M
What is the all time high annual EBITDA for Dynavax Technologies?
Dynavax Technologies all-time high annual earnings before interest, taxes, depreciation & amortization is $307.70 M
What is Dynavax Technologies annual EBITDA year-on-year change?
Over the past year, DVAX annual earnings before interest, taxes, depreciation & amortization has changed by -$298.03 M (-96.86%)
What is Dynavax Technologies quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DVAX is $23.28 M
What is the all time high quarterly EBITDA for Dynavax Technologies?
Dynavax Technologies all-time high quarterly earnings before interest, taxes, depreciation & amortization is $132.79 M
What is Dynavax Technologies quarterly EBITDA year-on-year change?
Over the past year, DVAX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$5.86 M (+33.61%)
What is Dynavax Technologies TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DVAX is $38.92 M
What is the all time high TTM EBITDA for Dynavax Technologies?
Dynavax Technologies all-time high TTM earnings before interest, taxes, depreciation & amortization is $340.08 M
What is Dynavax Technologies TTM EBITDA year-on-year change?
Over the past year, DVAX TTM earnings before interest, taxes, depreciation & amortization has changed by -$37.18 M (-48.86%)